Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
July 02, 2024 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
34 Lives has saved 10 lives with “unusable” kidneys — and they’re just getting started
June 19, 2024 15:07 ET
|
Purdue Research Foundation
WEST LAFAYETTE, IN, June 19, 2024 (GLOBE NEWSWIRE) -- New technologies are often referred to as life-changing, but that phrase quite literally describes the work that 34 Lives is doing for those...
American Kidney Fund Convenes Rare Kidney Disease Action Network to Advocate for Policies and Regulations that Help Patients with Rare Causes of Kidney Disease
June 13, 2024 13:07 ET
|
American Kidney Fund
ROCKVILLE, Md., June 13, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce the launch of the Rare Kidney Disease Action Network (RKDAN), a new effort that will play a...
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
June 03, 2024 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
May 30, 2024 16:47 ET
|
OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
American Kidney Fund’s New Know Your Kidneys Program Provides Roadmap to Better Kidney Health
May 13, 2024 10:09 ET
|
American Kidney Fund
ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced a major expansion of its award-winning Know Your Kidneys program, providing people at risk for kidney...
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
May 09, 2024 07:30 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
May 09, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at ATC 2024
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
May 07, 2024 07:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
May 07, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement